In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

Paratek Pharmaceuticals to acquire Optinose and its nasal drug-device Xhance for up to $330M, expanding beyond antibiotics ...

The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...

In contrast to generic ketamine, Spravato, an intranasal version of ketamine (esketamine), is FDA-approved and therefore is highly regulated. I’m amazed at the differences between the rollout of ...

Ketamine has gained attention for its depression treatment potential, particularly with the FDA approval of Spravato nasal spray. Market growth is driven by rising mental health issues, increasing ...